The U.S. Supreme Court declined on Monday to hear a bid by a group of physicians and healthcare providers to revive their ...

The latest update is out from GlaxoSmithKline ( (GB:GSK) ).

The Catawba County Public Health Community Health Workers program is dedicated to ensuring that all families in Catawba ...

GNG Electronics, Finolex Industries, Stove Kraft, TCS, Varun Beverages, ICICI Bank, GlaxoSmithKline Pharma, Diffusion ...

India's biotech boom, challenges, and strategic priorities for future growth in healthcare and life sciences discussed by ...

SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive ...

Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher ...

French drugmaker Sanofi and Britain's GlaxoSmithKline willsupply 200 million doses of their COVID-19 candidate vaccine to a globalinoculation scheme backed by the World Health Organization.

The chief executive of GlaxoSmithKline , the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.

Dame Emma Walmsley will step down as GSK’s chief executive at the end of the year, concluding nine years at the helm of Britain’s second-largest pharmaceuticals company. The £62bn FTSE giant announced ...

GSK said Emma Walmsley would step down after more than eight years as chief executive and named its commercial chief, Luke Miels, to succeed her in the top job. Walmsley, who became CEO of the U.K.

(Reuters) -GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on Monday, a surprise switch as the British firm looks to rev up its ...